Birdwatch Archive

Birdwatch Note

2024-07-31 16:14:58 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

イマネ・ケリフ選手はトランス女性ではありません。昨年度の失格は遺伝子検査で男性ホルモン値が高かった為ですが、性分化疾患やアンドロゲン過剰症の可能性があります。 https://brujulaintersexual.org/2023/04/07/pronunciamiento-contra-la-descalificacion-de-la-boxeadora-argelina-imane-khelif/ 性分化疾患とは http://jspe.umin.jp/public/seibunka.html アンドロゲン過剰症とは https://www.shouman.jp/disease/details/05_28_060/ 2024パリオリンピックはトランス女性の出場選手の指針として12歳以前に性転換手術をしたものとしており、実質的にトランス女性の出場は非常に難しくなっています。 https://www.newsweekjapan.jp/stories/culture/2024/07/post-105020.php https://www.thenation.com/article/society/trans-athletes-paris-olympics/tnamp/

Written by 15D729BDDAFD706F12F227554EB744E8AC9EDBB0C9451105AA4C9C410D47A84F
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1818586580073726164

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1818681772508639711
  • noteId - 1818681772508639711
  • participantId -
  • noteAuthorParticipantId - 15D729BDDAFD706F12F227554EB744E8AC9EDBB0C9451105AA4C9C410D47A84F Participant Details
  • createdAtMillis - 1722442498696
  • tweetId - 1818586580073726164
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • イマネ・ケリフ選手はトランス女性ではありません。昨年度の失格は遺伝子検査で男性ホルモン値が高かった為ですが、性分化疾患やアンドロゲン過剰症の可能性があります。 https://brujulaintersexual.org/2023/04/07/pronunciamiento-contra-la-descalificacion-de-la-boxeadora-argelina-imane-khelif/ 性分化疾患とは http://jspe.umin.jp/public/seibunka.html アンドロゲン過剰症とは https://www.shouman.jp/disease/details/05_28_060/ 2024パリオリンピックはトランス女性の出場選手の指針として12歳以前に性転換手術をしたものとしており、実質的にトランス女性の出場は非常に難しくなっています。 https://www.newsweekjapan.jp/stories/culture/2024/07/post-105020.php https://www.thenation.com/article/society/trans-athletes-paris-olympics/tnamp/

Note Ratings

rated at rated by
2024-08-01 13:01:23 -0500 Rating Details
2024-08-01 11:58:26 -0500 Rating Details
2024-08-01 10:52:52 -0500 Rating Details
2024-08-01 10:07:14 -0500 Rating Details
2024-08-01 10:04:30 -0500 Rating Details
2024-08-01 10:03:19 -0500 Rating Details
2024-08-01 09:55:58 -0500 Rating Details
2024-08-01 09:53:43 -0500 Rating Details
2024-08-01 09:46:59 -0500 Rating Details
2024-08-01 09:44:07 -0500 Rating Details
2024-08-01 09:43:21 -0500 Rating Details
2024-08-01 09:43:13 -0500 Rating Details
2024-08-01 09:33:04 -0500 Rating Details
2024-08-01 09:15:09 -0500 Rating Details
2024-08-01 09:05:53 -0500 Rating Details
2024-08-01 08:56:41 -0500 Rating Details
2024-08-01 08:33:00 -0500 Rating Details
2024-08-01 08:32:55 -0500 Rating Details
2024-08-01 08:29:21 -0500 Rating Details
2024-08-01 08:28:54 -0500 Rating Details
2024-08-01 08:28:49 -0500 Rating Details
2024-08-01 08:25:11 -0500 Rating Details
2024-08-01 08:20:11 -0500 Rating Details
2024-08-01 08:16:31 -0500 Rating Details
2024-08-01 08:11:03 -0500 Rating Details
2024-08-01 08:09:01 -0500 Rating Details
2024-08-01 07:54:11 -0500 Rating Details
2024-08-01 07:38:08 -0500 Rating Details
2024-08-01 07:28:04 -0500 Rating Details
2024-08-01 07:04:49 -0500 Rating Details
2024-08-01 07:04:12 -0500 Rating Details
2024-08-01 06:58:15 -0500 Rating Details
2024-08-01 04:33:58 -0500 Rating Details
2024-08-01 00:30:15 -0500 Rating Details
2024-07-31 22:48:34 -0500 Rating Details
2024-07-31 21:57:05 -0500 Rating Details
2024-07-31 21:17:49 -0500 Rating Details
2024-07-31 20:26:50 -0500 Rating Details
2024-07-31 20:05:25 -0500 Rating Details
2024-07-31 20:04:21 -0500 Rating Details
2024-07-31 19:58:28 -0500 Rating Details
2024-07-31 19:55:47 -0500 Rating Details
2024-07-31 19:37:24 -0500 Rating Details
2024-07-31 19:36:45 -0500 Rating Details
2024-07-31 19:04:23 -0500 Rating Details
2024-07-31 18:58:40 -0500 Rating Details
2024-07-31 18:22:44 -0500 Rating Details
2024-07-31 18:06:28 -0500 Rating Details
2024-07-31 18:02:23 -0500 Rating Details
2024-07-31 18:01:17 -0500 Rating Details
2024-07-31 17:56:22 -0500 Rating Details
2024-07-31 17:52:14 -0500 Rating Details
2024-07-31 17:49:39 -0500 Rating Details
2024-07-31 17:25:00 -0500 Rating Details
2024-07-31 17:06:28 -0500 Rating Details
2024-07-31 16:54:07 -0500 Rating Details
2024-07-31 16:51:10 -0500 Rating Details
2024-07-31 16:24:55 -0500 Rating Details
2024-07-31 16:23:43 -0500 Rating Details
2024-07-31 16:08:42 -0500 Rating Details
2024-07-31 16:04:23 -0500 Rating Details
2024-07-31 15:53:56 -0500 Rating Details
2024-07-31 15:19:21 -0500 Rating Details
2024-07-31 14:43:37 -0500 Rating Details
2024-07-31 13:09:44 -0500 Rating Details
2024-07-31 12:33:44 -0500 Rating Details
2024-07-31 12:09:59 -0500 Rating Details
2024-07-31 11:51:08 -0500 Rating Details
2024-07-31 11:30:53 -0500 Rating Details
2024-07-31 11:28:36 -0500 Rating Details